Akebia Therapeutics
AKBA
AKBA
124 hedge funds and large institutions have $58.3M invested in Akebia Therapeutics in 2022 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 40 increasing their positions, 43 reducing their positions, and 26 closing their positions.
Holders
124
Holders Change
-9
Holders Change %
-6.77%
% of All Funds
1.96%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
17
Increased
40
Reduced
43
Closed
26
Calls
$4.35M
Puts
$2.64M
Net Calls
+$1.71M
Net Calls Change
-$2.82M
Top Buyers
1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$10.3M |
2 |
2
Millennium Management
New York
|
$1.89M |
3 |
3
Renaissance Technologies
New York
|
$720K |
4 |
![]()
4
Group One Trading
Chicago,
Illinois
|
$289K |
5 |
5
UBS Group
Zurich,
Switzerland
|
$553K |